622 related articles for article (PubMed ID: 736651)
1. A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods.
Balch CM; Murad TM; Soong SJ; Ingalls AL; Halpern NB; Maddox WA
Ann Surg; 1978 Dec; 188(6):732-42. PubMed ID: 736651
[TBL] [Abstract][Full Text] [Related]
2. A multifactorial analysis of melanoma. II. Prognostic factors in patients with stage I (localized) melanoma.
Balch CM; Soong SJ; Murad TM; Ingalls AL; Maddox WA
Surgery; 1979 Aug; 86(2):343-51. PubMed ID: 462379
[TBL] [Abstract][Full Text] [Related]
3. [Survival analysis in patients with cutaneous malignant melanoma].
Radović-Kovacević V; Pekmezović T; Adanja B; Jarebinski M; Marinković J; Tomin R
Srp Arh Celok Lek; 1997; 125(5-6):132-7. PubMed ID: 9265233
[TBL] [Abstract][Full Text] [Related]
4. Treatment Outcome and Prognostic Factors for Malignant Skin Melanoma Treated with Radical Surgery.
Majewski W; Stanienda K; Wicherska K; Ulczok R; Wydmanski J
Asian Pac J Cancer Prev; 2015; 16(14):5709-14. PubMed ID: 26320440
[TBL] [Abstract][Full Text] [Related]
5. A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II).
Balch CM; Soong SJ; Murad TM; Ingalls AL; Maddox WA
Ann Surg; 1981 Mar; 193(3):377-88. PubMed ID: 7212800
[TBL] [Abstract][Full Text] [Related]
6. Malignant melanoma of the extremities: a clinicopathologic study using levels of invasion (microstage).
Wanebo HJ; Woodruff J; Fortner JG
Cancer; 1975 Mar; 35(3):666-76. PubMed ID: 1111935
[TBL] [Abstract][Full Text] [Related]
7. A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia.
Balch CM; Soong SJ; Milton GW; Shaw HM; McGovern VJ; Murad TM; McCarthy WH; Maddox WA
Ann Surg; 1982 Dec; 196(6):677-84. PubMed ID: 7149819
[TBL] [Abstract][Full Text] [Related]
8. The prognostic significance of ulceration of cutaneous melanoma.
Balch CM; Wilkerson JA; Murad TM; Soong SJ; Ingalls AL; Maddox WA
Cancer; 1980 Jun; 45(12):3012-7. PubMed ID: 7388745
[TBL] [Abstract][Full Text] [Related]
9. Selection of the optimum surgical treatment of stage I melanoma by depth of microinvasion: Use of the combined microstage technique (Clark-Breslow).
Wanebo HJ; Fortner JG; Woodruff J; MacLean B; Binkowski E
Ann Surg; 1975 Sep; 182(3):302-15. PubMed ID: 1164058
[TBL] [Abstract][Full Text] [Related]
10. A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III).
Balch CM; Soong SJ; Murad TM; Smith JW; Maddox WA; Durant JR
J Clin Oncol; 1983 Feb; 1(2):126-34. PubMed ID: 6668496
[TBL] [Abstract][Full Text] [Related]
11. Value of DNA ploidy and S-phase fraction as prognostic factors in stage III cutaneous melanoma.
Martin G; Halwani F; Shibata H; Meterissian S
Can J Surg; 2000 Feb; 43(1):29-34. PubMed ID: 10714254
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors for survival in malignant melanoma of the eyelid skin.
Esmaeli B; Wang B; Deavers M; Gillenwater A; Goepfert H; Diaz E; Eicher S
Ophthalmic Plast Reconstr Surg; 2000 Jul; 16(4):250-7. PubMed ID: 10923972
[TBL] [Abstract][Full Text] [Related]
13. Identification of higher risk thin melanomas should be based on Breslow depth not Clark level IV.
Owen SA; Sanders LL; Edwards LJ; Seigler HF; Tyler DS; Grichnik JM
Cancer; 2001 Mar; 91(5):983-91. PubMed ID: 11251950
[TBL] [Abstract][Full Text] [Related]
14. Updated statistical data for malignant melanoma in Japan.
Ishihara K; Saida T; Yamamoto A;
Int J Clin Oncol; 2001 Jun; 6(3):109-16. PubMed ID: 11706778
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of the primary lesion of malignant melanoma as a guide to prognosis and therapy.
Kapelanski DP; Block GE; Kaufman M
Ann Surg; 1979 Feb; 189(2):225-35. PubMed ID: 426555
[TBL] [Abstract][Full Text] [Related]
16. Prognostic subclassifications of T1 cutaneous melanomas based on ulceration, tumour thickness and Clark's level of invasion: results of a population-based study from the Swedish Melanoma Register.
Lyth J; Hansson J; Ingvar C; Månsson-Brahme E; Naredi P; Stierner U; Wagenius G; Lindholm C;
Br J Dermatol; 2013 Apr; 168(4):779-86. PubMed ID: 23066913
[TBL] [Abstract][Full Text] [Related]
17. Depth of invasion and tumor thickness in primary cutaneous malignant melanoma. A study of 2012 cases.
Søndergaard K
Acta Pathol Microbiol Immunol Scand A; 1985 Mar; 93(2):49-55. PubMed ID: 3984735
[TBL] [Abstract][Full Text] [Related]
18. Comparison of prognostic factors for survival and recurrence in malignant melanoma of the skin, clinical Stage I.
Johnson OK; Emrich LJ; Karakousis CP; Rao U; Greco WR
Cancer; 1985 Mar; 55(5):1107-17. PubMed ID: 3967194
[TBL] [Abstract][Full Text] [Related]
19. Pathological staging of melanoma.
Elder DE
Methods Mol Biol; 2014; 1102():325-51. PubMed ID: 24258986
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological Features and Prognostic Factors of Malignant Melanoma: A Retrospective Analysis of Thai Patients in Ramathibodi Hospital.
Ingkaninanda P; Visessiri Y; Rutnin S
J Med Assoc Thai; 2015 Aug; 98(8):820-7. PubMed ID: 26437541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
